The epidemiology of tuberculosis in the United States

Seminars in Respiratory and Critical Care Medicine

Volumn 29, Issue 5, 2008, Pages 492-498

  Burzynski, Joseph ^a   Schluger, Neil W ^b,c  

^a College of Physicians and Surgeons ^*  (United States)

^b Mailman School of Public Health ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Epidemiology; Mycobacterium tuberculosis; Public health; Tuberculosis; United States

Indexed keywords

BACTERIAL DNA; BCG VACCINE; ISONIAZID; RIFAMPICIN; RIFAPENTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CHINA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; DNA SEQUENCE; DOCTOR PATIENT RELATION; DOMINICAN REPUBLIC; HAITI; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMIGRATION; INCIDENCE; INFECTION RISK; MEXICO; MOLECULAR EPIDEMIOLOGY; MONOTHERAPY; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PHILIPPINES; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SOUTH AFRICA; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES;

ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; DIRECTLY OBSERVED THERAPY; EMIGRANTS AND IMMIGRANTS; HIV INFECTIONS; HUMANS; RISK FACTORS; TUBERCULOSIS; UNITED STATES;

EID: 53549134462     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0028-1085701     Document Type: Review

References (43)

1. Taylor Z, Nolan CM, Blumberg HM. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 2005; 54:1-81
2. Frieden TR, Lerner BH, Rutherford BR. Lessons from the 1800s: tuberculosis control in the new millennium. Lancet 2000;355:1088-1092
3. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-1395
4. Dubos R, Dubos J. The White Plague. Boston: Little, Brown; 1952
5. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144:745-749
6. Sidel VW, Drucker E, Martin SC. The resurgence of tuberculosis in the united states: societal origins and societal responses. J Law Med Ethics 1993;21:303-316
7. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521-526
8. Gandhi NR, Moll A, Sturm AW, et al. Extensively drugresistant tuberculosis as a cause of death in patients coinfected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-1580
9. Kremer K, van Soolingen D, Frothingham R, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 1999;37:2607-2618
10. van Embden JD, van Soolingen D, Small PM, Hermans PW. Genetic markers for the epidemiology of tuberculosis. Res Microbiol 1992;143:385-391
11. Van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Intern Med 2001;249:1-26
12. van Soolingen D, Hermans PW, de Haas PE, Soll DR, van Embden JD. Occurrence and stability of insertion sequences in mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 1991;29:2578-2586
13. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992;326:231-235
14. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-1709
15. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994;330:1710-1716
16. Geng E, Kreiswirth B, Burzynski J, Schluger NW. Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study. JAMA 2005; 293:2740-2745
17. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City-turning the tide. N Engl J Med 1995;333:229-233
18. CDC. Trends in tuberculosis incidence-United States, 2006. MMWR Morb Mortal Wkly Rep 2007;56:245-250
19. Trends in tuberculosis-United States, 2007. MMWR Morb Mortal Wkly Rep 2008;57:281-285
20. Muga R, Ferreros I, Langohr K, et al. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART. AIDS 2007; 21:2521-2527
21. Moh R, Danel C, Messou E, et al. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa. AIDS 2007;21:2483-2491
22. Albalak R, O'Brien RJ, Kammerer JS, et al. Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004. Arch Intern Med 2007;167:2443-2452
23. Zabana Y, Domenech E, San Roman AL, et al. Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy. Inflamm Bowel Dis 2008; May 1 [Epub ahead of print]
24. Leung CC, Lam TH, Chan WM, et al. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 2008; 167:1486-1494
25. Cain KP, Haley CA, Armstrong LR, et al. Tuberculosis among foreign-born persons in the united states: achieving tuberculosis elimination. Am J Respir Crit Care Med 2007; 175:75-79
26. Geng E, Kreiswirth B, Driver C, et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med 2002;346:1453-1458
27. Walter ND, Jasmer RM, Grinsdale J, Kawamura LM, Hopewell PC, Nahid P. Reaching the limits of tuberculosis prevention among foreign-born individuals: a tuberculosiscontrol program perspective. Clin Infect Dis 2008;46:103-106
28. Dahle UR, Eldholm V, Winje BA, Mannsaker T, Heldal E. Impact of immigration on the molecular epidemiology of Mycobacterium tuberculosis in a low-incidence country. Am J Respir Crit Care Med 2007;176:930-935
29. Brodie D, Lederer DJ, Gallardo JS, Trivedi SH, Burzynski JN, Schluger NW. Use of an interferon-gamma release assay to diagnose latent tuberculosis infection in foreign-born patients. Chest 2008;133:869-874
30. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-354
31. Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. J Infect Dis 2007; 196(Suppl 3):S482-S490
32. Wells CD, Cegielski JP, Nelson LJ, et al. Hiv infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007;196(Suppl l):S86-S107
33. Matteelli A, Migliori GB, Cirillo D, Centis R, Girard E, Raviglion M. Multidrug-resistant and extensively drugresistant Mycobacterium tuberculosis: epidemiology and control. Expert Rev Anti Infect Ther 2007;5:857-871
34. Bai GH, Park YK, Choi YW, et al. Trend of antituberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis 2007;11:571-576
35. Blondal K. Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis. Bull World Health Organ 2007;85:387-390; discussion 391-384
36. Zignol M, Hosseini MS, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006;194:479-485
37. Yerokhin W, Punga VV, Rybka LN. Tuberculosis in Russia and the problem of multiple drug resistance. Ann N Y Acad Sci 2001;953:133-137
38. Fujiwara PI, Cook SV, Rutherford CM, et al. A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch Intern Med 1997;157:531-536
39. Healthy People 2010. Washington, DC: Office of Health Promotion and Preventive Services, Department of Health and Human Services; 2000
40. Schwartzman K, Oxlade O, Barr RG, et al. Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med 2005;353:1008-1020
41. Khan K, Wang J, Hu W, Bierman A, Li Y, Gardam M. Tuberculosis infection in the United States: national trends over three decades. Am J Respir Crit Care Med 2008;177:455-460
42. Bennett DE, Courval JM, Onorato I, et al. Prevalence of tuberculosis infection in the United States population: the National Health and Nutrition Examination Survey, 1999-2000. Am J Respir Crit Care Med 2008;177:348-355
43. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007; 167:335-342